Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety
Casey W. Williamson, Michael V. Sherer, Dmitriy Zamarin, Andrew B. Sharabi, Brandon A. Dyer, Loren K. Mell, Jyoti Mayadev
Abstract
Radiation therapy exerts a tumoricidal local effect as well as both local and systemic immunomodulation. Immune checkpoint blockade has become a widely used treatment modality across cancer types with a rapidly growing list of agents and US Food and Drug Administration-approved indications. Moreover, there may be synergy between radiation therapy and immune checkpoint blockade. Various strategies have been used, but the optimal sequencing of these therapies is unclear. In this review, the authors discuss the major mechanisms of available immune checkpoint inhibitors and explore the available preclinical and clinical evidence regarding treatment sequencing. They also review safety considerations and conclude with possible future directions.